Condition: Laryngoscopic Stress Response · Dexmedetomidine · Lignocaine · Sponsor: Rawalpindi Institute of Cardiology
After confirming eligibility, written informed consent will be obtained by a trained team member who is not involved in assigning treatment or giving the study medication. Each participant will receive a unique study number to protect privacy. Participants will be randomly assigned to receive one of the study medications using a chance-based method.The study medication will be administered through a vein before placement of the breathing tube. Blood pressure and pulse rate will be measured before the procedure and at several time points after the breathing tube is inserted.
This description comes directly from the study's public registry record.
Namrah Zujaj, MBBS · +92 305 2636980 · zujajnamrah20@gmail.com
Always discuss trial participation with your own doctor first.
| Rawalpindi Institute of Cardiology | Rawalpindi, Punjab Province, Pakistan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07611890